Page last updated: 2024-08-17

colchicine and Cardiovascular Stroke

colchicine has been researched along with Cardiovascular Stroke in 103 studies

Research

Studies (103)

TimeframeStudies, this research(%)All Research%
pre-19902 (1.94)18.7374
1990's3 (2.91)18.2507
2000's4 (3.88)29.6817
2010's21 (20.39)24.3611
2020's73 (70.87)2.80

Authors

AuthorsStudies
Aguilhon, S; Akodad, M; Cardon, F; Cristol, JP; Delbaere, Q; Delseny, D; Dupasquier, V; Dupuy, AM; Gervasoni, R; Huet, F; Jammoul, N; Kahlouche, S; Leclercq, F; Macia, JC; Mariano-Goulart, D; Nagot, N; Roubille, F; Soltani, S1
Büyükulaş, C; Karahan, E; Polat, YO; Şen, S; Üresin, AY1
Budhathoki, P; Elgendy, I; Khadka, M; Mir, WAY; Patel, NK; Patel, T; Pokharel, S; Sedhai, Y; Shrestha, DB; Yadav, S1
He, QZ; Little, PJ; Qin, CH; Weng, JP; Xu, SW; Zhang, FS1
Chen, Y; Fu, Y; Jiang, Y; Li, M; Liu, Y; Luo, W; Wu, Y; Xia, H; Xu, C; Zhang, H1
Attar, A; Kazemi, A; Ramezani, A; Razavi, E1
Barhdadi, A; Dubé, MP; Hennessy, T; Hillis, GS; Rhainds, D; Schultz, CJ; Sun, M; Tardif, JC1
Shen, S; Shu, Y; Tang, X; Wan, H; Xiao, R; Zeng, L1
Aghakouchakzadeh, M; Alidoosti, M; Etesamifard, N; Gheymati, A; Hosseini, SH; Jalali, A; Jenab, Y; Kakavand, H; Sadeghian, M; Tajdini, M; Talasaz, AH; Van Tassell, BW1
Bao, YL; Du, C; Gu, LF; Wang, LS; Wang, YX1
Jiang, W; Song, X; Tian, J; Yong, J; Zhang, H; Zhao, X1
Bax, WA; Budgeon, CA; Cornel, JH; Eikelboom, JW; El Messaoudi, S; Fiolet, ATL; Mosterd, A; Nidorf, SM; Opstal, TSJ; Prins, FJ; Ronner, E; Schut, A; Thompson, PL; Tijssen, JGP1
Prayitnaningsih, S; Rohman, MS; Suryono, S; Widjajanto, E; Wihastuti, TA1
Chen, W; Fan, FD; Han, XK; Jiang, CY; Jiang, XY; Pan, J; Pan, T; Wang, CS; Wang, DJ; Wang, K; Zhang, H; Zhang, HT; Zhang, L; Zhou, Q1
Alam, M; Jhamnani, S; Jhaveri, A; Kontopantelis, E; Mamas, MA; Savinova, OV; Siddiqui, E1
De Sarro, G; Gallelli, L; Lochner, P; Siniscalchi, A1
Andel, PM; Atar, D; Aukrust, P; Gleditsch, J; Gude, E; Haugeberg, G; Høie, S; Salte, T; Steine, K1
Cai, X; Hu, S; Ji, L; Li, Z; Lin, C; Lv, F; Yang, W; Zhu, X1
Fuster, V; Nelson, K; Ridker, PM1
Oktaviono, YH; Prayitnaningsih, S; Rohman, MS; Suryono, S; Widjajanto, E; Wihastuti, TA1
Bajpai, R; Clarson, LE; Forrester, H; Mallen, CD; Muller, S; Padmanabhan, N; Partington, RJ; Roddy, E; Whittle, R1
Entezari-Maleki, T; Khezerlouy-Aghdam, N; Khiali, S; Namdar, H; Rezagholizadeh, A; Salehi, R; Sarbakhsh, P; Taban-Sadeghi, M1
He, X; Huang, S; Long, Q; Qi, Z; Qian, B; Shi, H; Wang, X; Ye, X; Zhang, Y; Zhao, Q; Zhong, Y1
Bax, WA; Budgeon, CA; Cornel, JH; Eikelboom, JW; Fiolet, ATL; Mosterd, A; Nidorf, SM; Opstal, TSJ; Schut, A; Thompson, PL; Tijssen, JGP1
Newby, LK1
Angoulvant, D; Berry, C; Bertrand, OF; Blondeau, L; Diaz, R; Dubé, MP; Gamra, H; Grégoire, JC; Guertin, MC; Ibrahim, R; Kiwan, GS; Koenig, W; Kouz, S; L'Allier, PL; Lavoie, MA; López-Sendón, J; Maggioni, AP; Orfanos, A; Ostadal, P; Pinto, FJ; Provencher, M; Rhainds, D; Roubille, F; Tardif, JC; Waters, DD1
Lim, GB1
Kashou, AH; May, AM; Noseworthy, PA1
Blumenthal, RS; Gulati, M; Mahtta, D; Mehta, A; Sperling, LS; Virani, SS1
Chen, Y; Ding, J; Jin, X; Liu, L; Miao, J; Shen, C; Shi, J; Yu, L; Zhang, Y; Zhao, Z1
Cauchon, M; Dussault, C; Huard, G; Lanthier, L; Plourde, MÉ2
Klingenberg, R; Nitschmann, S1
Lavalle-Cobo, A; Lobo, M; Masson, G; Masson, W; Molinero, G1
Abbasi, J1
Holzgreve, H1
Bach, RG1
Caspi, D; Elkayam, O; Furer, V1
Metzler, B; Reindl, M; Reinstadler, SJ1
Chiarito, M; Condorelli, G; Stefanini, GG1
Guertin, MC; L'Allier, PL; Tardif, JC1
Berry, C; Blondeau, L; Bouabdallaoui, N; Diaz, R; Dubé, MP; Gamra, H; Grégoire, JC; Guertin, MC; Ibrahim, R; Khairy, P; Kiwan, GS; Koenig, W; Kouz, S; L'Allier, PL; Lelorier, J; Lopez-Sendon, J; Maggioni, AP; Mitchell, D; Orfanos, A; Ostadal, P; Pinto, FJ; Provencher, M; Roubille, F; Samuel, M; Tardif, JC; Waters, DD1
Akodad, M; Fauconnier, J; Roubille, F; Sicard, P1
Alam, M; Jneid, H; Koneru, S; Mahtta, D; Silva, GV; Sudhakar, D; Virani, SS1
Berry, C; Bertrand, OF; Blondeau, L; Bouabdallaoui, N; Diaz, R; Dubé, MP; Gamra, H; Grégoire, JC; Guertin, MC; Ibrahim, R; Kiwan, GS; Koenig, W; Kouz, S; L'Allier, PL; Lim, P; Lopez-Sendon, J; Maggioni, AP; Morel, O; Orfanos, A; Pinto, FJ; Roubille, F; Samuel, M; Tardif, JC; Waters, DD1
Kraler, S; Lüscher, TF; Wenzl, FA1
Aimo, A; Barison, A; Bayes-Genis, A; Cediel, G; Emdin, M; Pascual-Figal, DA; Saccaro, LF; Vicente, ÁH1
Cornel, JH; Hoogeveen, RM; Stroes, ESG1
Lüscher, TF1
Aimo, A; Bayes-Genis, A; Emdin, M; Georgiopoulos, G; Pascual Figal, DA1
Huang, HK; Shih, MC; Tien, YY; Tu, YK1
Barraclough, J; Cochran, BJ; Kavurma, M; Khandkar, C; Kurup, R; Machet, J; Martinez, G; Misra, A; Pandzic, E; Patel, S; Rye, KA; Tucker, B; Vaidya, K1
Hiromasa, T; Inaki, A; Kinuya, S; Mori, H; Ogawa, K; Shiba, K; Taki, J; Wakabayashi, H1
Benchea, L; Covic, A; Kanbay, M; Siriopol, D; Tapoi, L1
Deftereos, SG; Giannopoulos, GV; Vrachatis, DA1
Blondeau, L; Bouabdallaoui, N; Tardif, JC1
Abdel-Latif, A; Abo-Aly, M; Shindo, K; Shokri, E; Wudexi, I1
Bouabdallaoui, N; Tardif, JC2
Angoulvant, D; Biere, L; Bochaton, T; Bouleti, C; Boutitie, F; Bresson, D; Croisille, P; De Bourguignon, C; Dhelens, C; Dubreuil, O; Dufay, N; El Jonhy, N; Elbaz, M; Ivanes, F; Maucort-Boulch, D; Mewton, N; Ovize, M; Prieur, C; Prunier, F; Rioufol, G; Roubille, F; Sideris, G1
Fu, C; Wang, B1
Budgeon, C; Cornel, JH; Eikelboom, JW; Fiolet, ATL; Jolly, SS; Keech, AC; Kelly, P; Layland, J; Mosterd, A; Nidorf, SM; Opstal, TSJ; Thompson, PL; Tijssen, JGP; Tong, DC1
Andreis, A; Avondo, S; Casula, M; De Ferrari, GM; Imazio, M; Paneva, E; Piroli, F1
Katira, A; Katira, R1
Mukherjee, D; Paul, TK1
Huang, X; Rao, L; Xiong, H; Zhao, J1
Hao, Y; Jiang, B; Wen, W; Zhang, Z1
Ebell, MH1
Cole, J; Freilich, M; Htun, N; Layland, J; Lew, R; Quinn, S1
Hota, D; Maiti, R; Sethuramalingam, S; Srinivasan, A1
Bajraktari, G; Banach, M; Bytyçi, I; Henein, MY; Penson, PE1
Akodad, M; Alos, B; Angoulvant, D; Bidaux, G; Biere, L; Bochaton, T; Bonnefoy-Cudraz, E; Bouleti, C; Boutitie, F; Bresson, D; Croisille, P; Daw, R; De Bourguignon, C; Derimay, F; Dhelens, C; Dubreuil, O; El Jonhy, N; Finet, G; Haider, L; Hayek, A; Ivanes, F; Maucort-Boulch, D; Mewton, N; Prieur, C; Prunier, F; Rioufol, G; Roubille, F1
Alcock, R; Barlis, P; Butters, J; Dautov, R; Di Giovanni, G; Montarello, NJ; Nerlekar, N; Nicholls, SJ; Nidorf, SM; Ottaway, JL; Patel, S; Psaltis, PJ; Rajendran, S; Salagaras, T; Singh, K; Sinhal, A; Thompson, PL; Wong, DTL1
Li, C; Li, Q; Li, Z; Lu, C; Peng, Y; Song, L; Wang, L; Wang, Y; Xia, D; Yu, A1
Marquis-Gravel, G; Tardif, JC1
Bax, WA; Budgeon, CA; Cornel, JH; den Hartog, F; Duyvendak, M; Eikelboom, JW; El Messaoudi, S; Fiolet, ATL; Mosterd, A; Nidorf, SM; Opstal, TSJ; Thompson, PL; Tijssen, JGP; van Beek, EA; van Broekhoven, A; van Eck, JWM1
Aguilhon, S; Akodad, M; Blandel, F; Bourret, A; de Santa Barbara, P; Fauconnier, J; Huet, F; Hugon, G; Lacampagne, A; LeGall, M; Roubille, F; Sicard, P1
Fujisue, K; Ishii, M; Izumiya, Y; Kaikita, K; Kurokawa, H; Matsubara, J; Sugamura, K; Sugiyama, S1
Bakhta, O; Blanchard, S; Guihot, AL; Jeannin, P; Mirebeau-Prunier, D; Prunier, F; Tamareille, S1
Chhabra, L; Kowlgi, NG; Spodick, DH1
Cornel, JH; Fiolet, ATL; Mosterd, A; Nidorf, SM1
Chatzidou, S; Iliopoulos, DC; Kaminiotis, VV; Kontogiannis, C; Moris, D; Paschou, SA; Siasos, G; Spartalis, E; Spartalis, M; Tsilimigras, DI; Tzatzaki, E; Voudris, V1
Bowman, M; Hennessy, T; Hillis, GS; Kurup, R; Patel, S; Schultz, C; Soh, L1
Deodhar, A1
Abenhaim, L; Alpérovitch, A; Aubrun, E; Danchin, N; Grimaldi-Bensouda, L; Richette, P; Rossignol, M1
Abad, E; Alburquerque-Béjar, JJ; Fernández-Sanz, C; García-Dorado, D; Inserte, J; Rodríguez-Sinovas, A; Ruiz-Meana, M; Sánchez, JA1
Alexopoulos, D; Alexopoulos, N; Angelidis, C; Cleman, MW; Deftereos, S; Filippatos, G; Giannopoulos, G; Goudevenos, J; Lekakis, J; Manolis, AS; Papoutsidakis, N; Pyrgakis, V; Sianos, G; Tousoulis, D1
Arpagaus, A; Briel, M; Ewald, H; Glinz, D; Gloy, VL; Hemkens, LG; Nidorf, M; Nordmann, AJ; Olu, KK2
Ben-Shoshan, J; Entin-Meer, M; Hertzberg-Bigelman, E; Keren, G; Levy, R; Margolis, G1
Briel, M; Ewald, H; Hemkens, LG1
Amoura, Z; Cacoub, P; Geri, G; Isnard, R; Piette, JC; Resche-Rigon, M; Saadoun, D; Thi Huong, DL; Wechsler, B1
Crittenden, DB; Cronstein, BN; Greenberg, JD; Keenan, RT; Lehmann, RA; Pillinger, MH; Schneck, L; Sedlis, SP; Shah, B1
Bansal, A; Gupta, I; Jones, J; Mankal, P; Ranade, A; Sandhu, G; Tagani, A1
HILLECKE, NA1
Ichikawa, Y; Ikeda, Y; Kobayashi, H; Miki, T; Miura, T; Nakamura, Y; Nakano, A; Shimamoto, K; Yano, T1
Hillis, LD; Lange, RA1
Bidwell, S; Davison, C; Phibbs, R; Than, M; Walker, M1
Cason, BA; Hickey, RF; Ismaeil, MS; Tkachenko, I1
Sharma, A; Singh, M1
Chaldakov, GN1
Jakobsen, TJ; Madsen, SM1
Smith, CR1

Reviews

35 review(s) available for colchicine and Cardiovascular Stroke

ArticleYear
Colchicine for cardiovascular therapy: A drug interaction perspective and a safety meta-analysis.
    Anatolian journal of cardiology, 2021, Volume: 25, Issue:11

    Topics: Colchicine; Coronary Artery Disease; Drug Interactions; Humans; Myocardial Infarction

2021
Colchicine for Patients With Coronary Artery Disease: A Systematic Review and Meta-analysis.
    Journal of cardiovascular pharmacology, 2022, 04-01, Volume: 79, Issue:4

    Topics: Anti-Inflammatory Agents; Colchicine; Coronary Artery Disease; Humans; Myocardial Infarction; Stroke

2022
Therapeutic potential of colchicine in cardiovascular medicine: a pharmacological review.
    Acta pharmacologica Sinica, 2022, Volume: 43, Issue:9

    Topics: Anti-Inflammatory Agents; Cardiovascular Agents; Colchicine; Coronary Artery Disease; COVID-19 Drug Treatment; Humans; Myocardial Infarction

2022
Colchicine may become a new cornerstone therapy for coronary artery disease: a meta-analysis of randomized controlled trials.
    Clinical rheumatology, 2022, Volume: 41, Issue:6

    Topics: Colchicine; Coronary Artery Disease; Humans; Ischemic Stroke; Myocardial Infarction; Randomized Controlled Trials as Topic

2022
Effect of Treatment with Colchicine after Acute Coronary Syndrome on Major Cardiovascular Events: A Systematic Review and Meta-Analysis of Clinical Trials.
    Cardiovascular therapeutics, 2022, Volume: 2022

    Topics: Acute Coronary Syndrome; C-Reactive Protein; Colchicine; Humans; Myocardial Infarction; Stroke

2022
Colchicine linked with risk reduction for myocardial infarction in gout patients: systematic review and meta-analysis.
    Zeitschrift fur Rheumatologie, 2022, Volume: 81, Issue:6

    Topics: Colchicine; Gout; Gout Suppressants; Humans; Myocardial Infarction; Risk Reduction Behavior

2022
Evaluating the Utility of Colchicine in Acute Coronary Syndrome: A Systematic Review and Meta-Analysis.
    Journal of cardiovascular pharmacology, 2022, 11-01, Volume: 80, Issue:5

    Topics: Acute Coronary Syndrome; Cause of Death; Colchicine; Humans; Myocardial Infarction; Stroke

2022
Efficacy of Colchicine in the Treatment of Patients With Coronary Artery Disease: A Mini-Review.
    Clinical therapeutics, 2022, Volume: 44, Issue:8

    Topics: Acute Coronary Syndrome; Anti-Inflammatory Agents; Colchicine; Coronary Artery Disease; Humans; Myocardial Infarction

2022
Meta-analysis of the effect of colchicine on C-reactive protein in patients with acute and chronic coronary syndromes.
    Coronary artery disease, 2023, 05-01, Volume: 34, Issue:3

    Topics: Acute Coronary Syndrome; Anti-Inflammatory Agents; Biomarkers; C-Reactive Protein; Colchicine; Coronary Artery Disease; Humans; Myocardial Infarction; Percutaneous Coronary Intervention

2023
Anti-inflammatory therapies were associated with reduced risk of myocardial infarction in patients with established cardiovascular disease or high cardiovascular risks: A systematic review and meta-analysis of randomized controlled trials.
    Atherosclerosis, 2023, Volume: 379

    Topics: Aged; Anti-Inflammatory Agents; Cardiovascular Diseases; Colchicine; Heart Failure; Humans; Interleukin-1; Interleukin-6; Myocardial Infarction; Randomized Controlled Trials as Topic; Stroke

2023
Low-Dose Colchicine for Secondary Prevention of Coronary Artery Disease: JACC Review Topic of the Week.
    Journal of the American College of Cardiology, 2023, 08-15, Volume: 82, Issue:7

    Topics: Adult; Atherosclerosis; Cholesterol, LDL; Colchicine; Coronary Artery Disease; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Myocardial Infarction; Secondary Prevention

2023
Cardiovascular Disease Prevention in Focus: Highlights from the 2019 American Heart Association Scientific Sessions.
    Current atherosclerosis reports, 2020, 01-11, Volume: 22, Issue:1

    Topics: American Heart Association; Antibodies, Monoclonal, Humanized; Anticholesteremic Agents; Atherosclerosis; Colchicine; Eicosapentaenoic Acid; Humans; Interleukin-6; Mutation; Myocardial Infarction; PCSK9 Inhibitors; Receptors, Interleukin-6; Risk Factors; United States

2020
Role of Colchicine in Stroke Prevention: An Updated Meta-Analysis.
    Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, 2020, Volume: 29, Issue:5

    Topics: Anti-Inflammatory Agents; Colchicine; Humans; Incidence; Myocardial Infarction; Protective Factors; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Stroke; Time Factors; Treatment Outcome

2020
    MMW Fortschritte der Medizin, 2020, Volume: 162, Issue:5

    Topics: Colchicine; Humans; Inflammation; Myocardial Infarction

2020
Colchicine and myocardial infarction: A review.
    Archives of cardiovascular diseases, 2020, Volume: 113, Issue:10

    Topics: Animals; Anti-Inflammatory Agents; Colchicine; Humans; Inflammation; Inflammation Mediators; Myocardial Infarction; Myocarditis; Myocardium; Signal Transduction; Treatment Outcome

2020
Targeting Inflammation After Myocardial Infarction.
    Current cardiology reports, 2020, 08-08, Volume: 22, Issue:10

    Topics: Colchicine; Humans; Inflammation; Myocardial Infarction

2020
Colchicine for the treatment of coronary artery disease.
    Trends in cardiovascular medicine, 2021, Volume: 31, Issue:8

    Topics: Acute Coronary Syndrome; Atherosclerosis; Colchicine; Coronary Artery Disease; Humans; Myocardial Infarction

2021
Effect of low-dose colchicine in acute and chronic coronary syndromes: A systematic review and meta-analysis.
    European journal of clinical investigation, 2021, Volume: 51, Issue:4

    Topics: Acute Coronary Syndrome; Angina Pectoris; Colchicine; Coronary Artery Disease; Dose-Response Relationship, Drug; Gout Suppressants; Humans; Myocardial Infarction; Proportional Hazards Models

2021
Drug repurposing? Cardiovascular effect of colchicine on patients with coronary artery disease: A systematic review and meta-analysis.
    Journal of cardiology, 2021, Volume: 77, Issue:6

    Topics: Colchicine; Coronary Artery Disease; Drug Repositioning; Humans; Myocardial Infarction; Percutaneous Coronary Intervention; Treatment Outcome

2021
Colchicine Use in Acute Coronary Syndromes: An Update.
    Angiology, 2021, Volume: 72, Issue:6

    Topics: Acute Coronary Syndrome; Animals; Anti-Inflammatory Agents; Cardiovascular Agents; Cardiovascular System; Colchicine; Humans; Myocardial Infarction; Signal Transduction; Treatment Outcome

2021
Comparative Effectiveness of Anti-Inflammatory Drug Treatments in Coronary Heart Disease Patients: A Systematic Review and Network Meta-Analysis.
    Mediators of inflammation, 2021, Volume: 2021

    Topics: Adult; Aged; Anti-Inflammatory Agents; Colchicine; Comparative Effectiveness Research; Coronary Circulation; Female; Follow-Up Studies; Heart Diseases; Humans; Male; Middle Aged; Myocardial Infarction; Network Meta-Analysis; Randomized Controlled Trials as Topic; Stroke; Treatment Outcome

2021
Colchicine administration for percutaneous coronary intervention: A meta-analysis of randomized controlled trials.
    The American journal of emergency medicine, 2021, Volume: 46

    Topics: Anti-Inflammatory Agents; Colchicine; Humans; Myocardial Infarction; Percutaneous Coronary Intervention; Randomized Controlled Trials as Topic; Treatment Outcome

2021
Efficacy and safety of low-dose colchicine in patients with coronary disease: a systematic review and meta-analysis of randomized trials.
    European heart journal, 2021, 07-21, Volume: 42, Issue:28

    Topics: Colchicine; Coronary Artery Disease; Humans; Myocardial Infarction; Randomized Controlled Trials as Topic; Stroke; Treatment Outcome

2021
Efficacy and safety of colchicine for the prevention of major cardiovascular and cerebrovascular events in patients with coronary artery disease: a systematic review and meta-analysis on 12 869 patients.
    European journal of preventive cardiology, 2022, 02-03, Volume: 28, Issue:17

    Topics: Colchicine; Coronary Artery Disease; Humans; Myocardial Infarction; Secondary Prevention; Stroke

2022
Colchicine in coronary artery disease.
    Postgraduate medical journal, 2022, Volume: 98, Issue:1163

    Topics: Acute Coronary Syndrome; Atherosclerosis; Colchicine; Coronary Artery Disease; Humans; Myocardial Infarction

2022
Colchicine Reduces MI and Revascularization in Patients with Established Coronary Artery Disease.
    American family physician, 2021, 05-15, Volume: 103, Issue:10

    Topics: Colchicine; Coronary Artery Disease; Global Health; Humans; Incidence; Myocardial Infarction; Percutaneous Coronary Intervention; Risk Factors; Treatment Outcome; Tubulin Modulators

2021
Effect of Colchicine in Reducing Inflammatory Biomarkers and Cardiovascular Risk in Coronary Artery Disease: A Meta-analysis of Clinical Trials.
    American journal of therapeutics, 2023, May-01, Volume: 30, Issue:3

    Topics: Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Clinical Trials as Topic; Colchicine; Coronary Artery Disease; Heart Disease Risk Factors; Humans; Inflammation; Myocardial Infarction; Risk Factors

2023
Colchicine in the Management of Acute and Chronic Coronary Artery Disease.
    Current cardiology reports, 2021, 07-16, Volume: 23, Issue:9

    Topics: Anti-Inflammatory Agents; Atherosclerosis; Colchicine; Coronary Artery Disease; Humans; Myocardial Infarction

2021
Efficacy and safety of colchicine in patients with coronary artery disease: A systematic review and meta-analysis of randomized controlled trials.
    British journal of clinical pharmacology, 2022, Volume: 88, Issue:4

    Topics: C-Reactive Protein; Colchicine; Coronary Artery Disease; Humans; Myocardial Infarction; Randomized Controlled Trials as Topic; Stroke; Treatment Outcome

2022
Colchicine in Stable Coronary Artery Disease.
    Clinical therapeutics, 2019, Volume: 41, Issue:1

    Topics: Anti-Inflammatory Agents; Colchicine; Coronary Artery Disease; Gout; Humans; Inflammation; Myocardial Infarction; Plaque, Atherosclerotic; Randomized Controlled Trials as Topic; Secondary Prevention

2019
The Beneficial Therapy with Colchicine for Atherosclerosis via Anti-inflammation and Decrease in Hypertriglyceridemia.
    Cardiovascular & hematological agents in medicinal chemistry, 2018, Volume: 16, Issue:2

    Topics: Acute Coronary Syndrome; Animals; Anti-Inflammatory Agents; Atherosclerosis; Colchicine; Coronary Artery Disease; Humans; Hypertriglyceridemia; Hypolipidemic Agents; Inflammation; Myocardial Infarction; Plaque, Atherosclerotic

2018
Colchicine for prevention of cardiovascular events.
    The Cochrane database of systematic reviews, 2016, Jan-27, Issue:1

    Topics: Anti-Inflammatory Agents; Cardiovascular Diseases; Cause of Death; Colchicine; Heart Failure; Humans; Myocardial Infarction; Randomized Controlled Trials as Topic; Risk; Stroke

2016
Cardiovascular effects and safety of long-term colchicine treatment: Cochrane review and meta-analysis.
    Heart (British Cardiac Society), 2016, Volume: 102, Issue:8

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Cardiovascular Diseases; Colchicine; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Myocardial Infarction; Treatment Outcome

2016
Spectrum of cardiac lesions in Behçet disease: a series of 52 patients and review of the literature.
    Medicine, 2012, Volume: 91, Issue:1

    Topics: Adult; Anticoagulants; Behcet Syndrome; Cohort Studies; Colchicine; Coronary Thrombosis; Endocarditis; Endomyocardial Fibrosis; Female; Heart Aneurysm; Humans; Immunosuppressive Agents; Male; Myocardial Infarction; Myocardium; Pericarditis; Sex Factors; Treatment Outcome

2012
Clinical practice. Acute pericarditis.
    The New England journal of medicine, 2004, Nov-18, Volume: 351, Issue:21

    Topics: Acute Disease; Adult; Anti-Inflammatory Agents, Non-Steroidal; Chest Pain; Colchicine; Diagnosis, Differential; Drug Therapy, Combination; Electrocardiography; Female; Glucocorticoids; Hospitalization; Humans; Myocardial Infarction; Pericarditis; Pulmonary Embolism; Recurrence

2004

Trials

16 trial(s) available for colchicine and Cardiovascular Stroke

ArticleYear
Colchicine to Prevent Sympathetic Denervation after an Acute Myocardial Infarction: The COLD-MI Trial Protocol.
    Medicina (Kaunas, Lithuania), 2021, Sep-30, Volume: 57, Issue:10

    Topics: Animals; Colchicine; Humans; Mice; Myocardial Infarction; Percutaneous Coronary Intervention; Prospective Studies; Randomized Controlled Trials as Topic; ST Elevation Myocardial Infarction; Sympathectomy

2021
Low-dose colchicine and high-sensitivity C-reactive protein after myocardial infarction: A combined analysis using individual patient data from the COLCOT and LoDoCo-MI studies.
    International journal of cardiology, 2022, 09-15, Volume: 363

    Topics: Biomarkers; C-Reactive Protein; Colchicine; Humans; Inflammation; Myocardial Infarction

2022
Preprocedural Colchicine in Patients With Acute ST-elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention: A Randomized Controlled Trial (PodCAST-PCI).
    Journal of cardiovascular pharmacology, 2022, 10-01, Volume: 80, Issue:4

    Topics: Arrhythmias, Cardiac; C-Reactive Protein; Colchicine; Humans; Myocardial Infarction; P-Selectin; Percutaneous Coronary Intervention; ST Elevation Myocardial Infarction; Treatment Outcome; Troponin

2022
Drivers of mortality in patients with chronic coronary disease in the low-dose colchicine 2 trial.
    International journal of cardiology, 2023, 02-01, Volume: 372

    Topics: Aged; Chronic Disease; Colchicine; Coronary Disease; Heart Diseases; Humans; Myocardial Infarction

2023
The low-dose colchicine in patients after non-CABG cardiac surgery: a randomized controlled trial.
    Critical care (London, England), 2023, 02-07, Volume: 27, Issue:1

    Topics: Biomarkers; Colchicine; Creatine Kinase, MB Form; Humans; Interleukin-6; Myocardial Infarction; Troponin I; Troponin T

2023
Effect of Colchicine in reducing MMP-9, NOX2, and TGF- β1 after myocardial infarction.
    BMC cardiovascular disorders, 2023, 09-11, Volume: 23, Issue:1

    Topics: Aged; Colchicine; Humans; Matrix Metalloproteinase 9; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; ST Elevation Myocardial Infarction; Transforming Growth Factor beta1; Ventricular Remodeling

2023
Empagliflozin and colchicine in patients with reduced left ventricular ejection fraction following ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: a study protocol for a randomized, double-blinded, three-arm paral
    Trials, 2023, Oct-06, Volume: 24, Issue:1

    Topics: Colchicine; Glucose; Heart Failure; Humans; Myocardial Infarction; Percutaneous Coronary Intervention; Prospective Studies; Randomized Controlled Trials as Topic; Sodium; Sodium-Glucose Transporter 2 Inhibitors; ST Elevation Myocardial Infarction; Stroke Volume; Ventricular Function, Left

2023
The effect of low-dose colchicine in patients with stable coronary artery disease: The LoDoCo2 trial rationale, design, and baseline characteristics.
    American heart journal, 2019, Volume: 218

    Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Atherosclerosis; Australia; Cardiovascular Diseases; Clinical Trial Protocols as Topic; Colchicine; Coronary Artery Disease; Double-Blind Method; Drug Administration Schedule; Drug Repositioning; Female; Humans; Male; Middle Aged; Myocardial Infarction; Netherlands; Percutaneous Coronary Intervention; Secondary Prevention; Stroke; Tubulin Modulators

2019
Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction.
    The New England journal of medicine, 2019, 12-26, Volume: 381, Issue:26

    Topics: Aged; Angina Pectoris; Anti-Inflammatory Agents; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Colchicine; Double-Blind Method; Female; Humans; Incidence; Intention to Treat Analysis; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Proportional Hazards Models; Recurrence; Stroke

2019
Cost-effectiveness of low-dose colchicine after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT).
    European heart journal. Quality of care & clinical outcomes, 2021, 09-16, Volume: 7, Issue:5

    Topics: Canada; Colchicine; Cost-Benefit Analysis; Humans; Myocardial Infarction; Quality-Adjusted Life Years

2021
Time-to-treatment initiation of colchicine and cardiovascular outcomes after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT).
    European heart journal, 2020, 11-07, Volume: 41, Issue:42

    Topics: Angina Pectoris; Colchicine; Humans; Myocardial Infarction; Stroke; Time-to-Treatment; Treatment Outcome

2020
Colchicine for Left Ventricular Infarct Size Reduction in Acute Myocardial Infarction: A Phase II, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Protocol - The COVERT-MI Study.
    Cardiology, 2021, Volume: 146, Issue:2

    Topics: Adult; Clinical Trials, Phase II as Topic; Colchicine; Humans; Magnetic Resonance Imaging; Multicenter Studies as Topic; Myocardial Infarction; Percutaneous Coronary Intervention; Prospective Studies; Randomized Controlled Trials as Topic; Stroke Volume; Treatment Outcome; Ventricular Function, Left

2021
Colchicine to Prevent Periprocedural Myocardial Injury in Percutaneous Coronary Intervention: The COPE-PCI Pilot Trial.
    Circulation. Cardiovascular interventions, 2021, Volume: 14, Issue:5

    Topics: Colchicine; Humans; Myocardial Infarction; Percutaneous Coronary Intervention; Pilot Projects; Treatment Outcome; Troponin I

2021
Assessing the Impact of Colchicine on Coronary Plaque Phenotype After Myocardial Infarction with Optical Coherence Tomography: Rationale and Design of the COCOMO-ACS Study.
    Cardiovascular drugs and therapy, 2022, Volume: 36, Issue:6

    Topics: Acute Coronary Syndrome; Colchicine; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; Double-Blind Method; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipids; Myocardial Infarction; Phenotype; Plaque, Atherosclerotic; Tomography, Optical Coherence

2022
Colchicine in Patients With Chronic Coronary Disease in Relation to Prior Acute Coronary Syndrome.
    Journal of the American College of Cardiology, 2021, 08-31, Volume: 78, Issue:9

    Topics: Acute Coronary Syndrome; Colchicine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Monitoring; Female; Gout Suppressants; Humans; Incidence; Male; Middle Aged; Myocardial Infarction; Outcome Assessment, Health Care; Risk Assessment; Secondary Prevention; Stroke; Time-to-Treatment

2021
Anti-Inflammatory Treatment With Colchicine in Acute Myocardial Infarction: A Pilot Study.
    Circulation, 2015, Oct-13, Volume: 132, Issue:15

    Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Area Under Curve; Biomarkers; C-Reactive Protein; Colchicine; Creatine Kinase, MB Form; Double-Blind Method; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Myocardial Infarction; Myocardium; Pilot Projects; Prospective Studies

2015

Other Studies

52 other study(ies) available for colchicine and Cardiovascular Stroke

ArticleYear
Colchicine as potential inhibitor targeting MMP-9, NOX2 and TGF-β1 in myocardial infarction: a combination of docking and molecular dynamic simulation study.
    Journal of biomolecular structure & dynamics, 2023, Volume: 41, Issue:21

    Topics: Colchicine; Humans; Matrix Metalloproteinase 9; Molecular Docking Simulation; Molecular Dynamics Simulation; Myocardial Infarction; Transforming Growth Factor beta1; Ventricular Remodeling

2023
Is Colchicine Involved in Managing Stroke?
    Current vascular pharmacology, 2023, Volume: 21, Issue:3

    Topics: Colchicine; Humans; Myocardial Infarction; Stroke

2023
Recurrent pericarditis.
    Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 2023, 05-30, Volume: 143, Issue:8

    Topics: Colchicine; Humans; Inflammation; Myocardial Infarction; Pericarditis; Recurrence

2023
Safety of colchicine and NSAID prophylaxis when initiating urate-lowering therapy for gout: propensity score-matched cohort studies in the UK Clinical Practice Research Datalink.
    Annals of the rheumatic diseases, 2023, Volume: 82, Issue:12

    Topics: Adult; Allopurinol; Anti-Inflammatory Agents, Non-Steroidal; Cohort Studies; Colchicine; Diarrhea; Gout; Gout Suppressants; Humans; Myocardial Infarction; Propensity Score; Retrospective Studies; United Kingdom; Uric Acid

2023
Localized delivery of anti-inflammatory agents using extracellular matrix-nanostructured lipid carriers hydrogel promotes cardiac repair post-myocardial infarction.
    Biomaterials, 2023, Volume: 302

    Topics: Animals; Anti-Inflammatory Agents; Colchicine; Drug Carriers; Hydrogels; Lipids; Mice; Myocardial Infarction; Nanostructures; Particle Size

2023
Inflammation as a Treatment Target after Acute Myocardial Infarction.
    The New England journal of medicine, 2019, 12-26, Volume: 381, Issue:26

    Topics: Colchicine; Humans; Inflammation; Myocardial Infarction

2019
Anti-inflammatory therapy for secondary prevention after MI.
    Nature reviews. Cardiology, 2020, Volume: 17, Issue:2

    Topics: Anti-Inflammatory Agents; Colchicine; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Secondary Prevention

2020
85-Year-Old Man With Chest Pain.
    Mayo Clinic proceedings, 2020, Volume: 95, Issue:1

    Topics: Aged, 80 and over; Anti-Inflammatory Agents; Aspirin; Chest Pain; Colchicine; Diagnosis, Differential; Electrocardiography; Humans; Magnetic Resonance Imaging, Cine; Male; Myocardial Infarction; Percutaneous Coronary Intervention; Pericarditis; Platelet Aggregation Inhibitors; Postoperative Complications; Proton Pump Inhibitors; Treatment Outcome; Troponin

2020
An injectable thermosensitive hydrogel loaded with an ancient natural drug colchicine for myocardial repair after infarction.
    Journal of materials chemistry. B, 2020, 02-07, Volume: 8, Issue:5

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Movement; Cell Proliferation; Colchicine; Hydrogels; Injections, Intralesional; Injections, Subcutaneous; Male; Materials Testing; Mice; Mice, Inbred C57BL; Molecular Structure; Myocardial Infarction; Particle Size; Polyesters; Polyethylene Glycols; Surface Properties; Temperature

2020
[In patients with recent myocardial infarction, is colchicine effective in preventing cardiovascular events with a safety profile equivalent to placebo?]
    La Revue de medecine interne, 2020, Volume: 41, Issue:3

    Topics: Adult; Aged; Cardiovascular Diseases; Chronic Disease; Colchicine; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Middle Aged; Myocardial Infarction; Placebos; Randomized Controlled Trials as Topic; Treatment Outcome

2020
[Colchicine treatment after myocardial infarction : Colchicine Cardiovascular Outcomes Trial (COLCOT)].
    Der Internist, 2020, Volume: 61, Issue:7

    Topics: Anti-Inflammatory Agents; Cardiovascular Diseases; Cardiovascular System; Colchicine; Gout Suppressants; Humans; Myocardial Infarction; Tubulin Modulators

2020
Cardiovascular Corner-Stable Coronary Artery Disease, An LDL "Vaccine," and Anti-inflammatories.
    JAMA, 2020, Apr-07, Volume: 323, Issue:13

    Topics: Angioplasty, Balloon, Coronary; Anti-Inflammatory Agents; Anticholesteremic Agents; Cholesterol, LDL; Colchicine; Combined Modality Therapy; Coronary Artery Disease; Humans; Hypercholesterolemia; Inflammation; Myocardial Infarction; RNA, Small Interfering

2020
Low-dose colchicine after MI reduced a composite ischemic cardiovascular outcome vs placebo.
    Annals of internal medicine, 2020, 04-21, Volume: 172, Issue:8

    Topics: Colchicine; Humans; Myocardial Infarction

2020
Low-Dose Colchicine after Myocardial Infarction.
    The New England journal of medicine, 2020, 04-23, Volume: 382, Issue:17

    Topics: C-Reactive Protein; Colchicine; Humans; Myocardial Infarction

2020
Low-Dose Colchicine after Myocardial Infarction.
    The New England journal of medicine, 2020, 04-23, Volume: 382, Issue:17

    Topics: C-Reactive Protein; Colchicine; Humans; Myocardial Infarction

2020
Low-Dose Colchicine after Myocardial Infarction.
    The New England journal of medicine, 2020, 04-23, Volume: 382, Issue:17

    Topics: C-Reactive Protein; Colchicine; Humans; Myocardial Infarction

2020
Low-Dose Colchicine after Myocardial Infarction. Reply.
    The New England journal of medicine, 2020, 04-23, Volume: 382, Issue:17

    Topics: C-Reactive Protein; Colchicine; Humans; Myocardial Infarction

2020
Repurposing Colchicine to Combat Residual Cardiovascular Risk: The LoDoCo2 Trial.
    European journal of clinical investigation, 2020, Volume: 50, Issue:12

    Topics: Cardiovascular Diseases; Colchicine; Heart Disease Risk Factors; Humans; Myocardial Infarction; Risk Factors

2020
[In patients with stable chronic coronary disease, how effective is colchicine in preventing cardiovascular events and what are the adverse reactions when compared to placebo?]
    La Revue de medecine interne, 2020, Volume: 41, Issue:12

    Topics: Chronic Disease; Colchicine; Coronary Disease; Heart Diseases; Humans; Myocardial Infarction

2020
[Anti-inflammatory therapy in cardiovascular disease; from hypothesis to future guideline?]
    Nederlands tijdschrift voor geneeskunde, 2020, 10-22, Volume: 164

    Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Cardiovascular Diseases; Colchicine; Humans; Inflammation; Methotrexate; Myocardial Infarction; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Translational Research, Biomedical

2020
The sooner, the better: anti-inflammation in acute myocardial infarction.
    European heart journal, 2020, 11-07, Volume: 41, Issue:42

    Topics: Anti-Inflammatory Agents; Cardiovascular System; Colchicine; Humans; Myocardial Infarction; Time-to-Treatment

2020
Colchicine Inhibits Neutrophil Extracellular Trap Formation in Patients With Acute Coronary Syndrome After Percutaneous Coronary Intervention.
    Journal of the American Heart Association, 2021, 01-05, Volume: 10, Issue:1

    Topics: Acute Coronary Syndrome; Angina, Stable; Anti-Inflammatory Agents; Colchicine; Extracellular Traps; Female; Humans; In Vitro Techniques; Inflammation; Male; Middle Aged; Myocardial Infarction; Neutrophil Activation; Neutrophils; Percutaneous Coronary Intervention; Treatment Outcome

2021
Colchicine treatment early after infarction attenuates myocardial inflammatory response demonstrated by
    Annals of nuclear medicine, 2021, Volume: 35, Issue:2

    Topics: Animals; Carbon Radioisotopes; Colchicine; Heart Ventricles; Humans; Male; Methionine; Myocardial Infarction; Myocardium; Radiopharmaceuticals; Rats; Rats, Wistar; Risk Assessment; Stroke Volume; Technetium; Tomography, Emission-Computed, Single-Photon; Ventricular Function, Left; Ventricular Remodeling

2021
Colchicine administered early in acute myocardial infarction: ready, set … go?
    European heart journal, 2021, 07-21, Volume: 42, Issue:28

    Topics: Colchicine; Humans; Myocardial Infarction; Percutaneous Coronary Intervention

2021
Lessons from COLCOT and LoDoCo2: colchicine for secondary prevention in coronary artery disease.
    European heart journal, 2021, 07-21, Volume: 42, Issue:28

    Topics: Atherosclerosis; Colchicine; Coronary Artery Disease; Humans; Myocardial Infarction; Secondary Prevention

2021
Initiation of low-dose colchicine early after myocardial infarction.
    European heart journal, 2021, 07-21, Volume: 42, Issue:28

    Topics: C-Reactive Protein; Cognition; Colchicine; Humans; Myocardial Infarction

2021
Is Colchicine Beneficial for the Prevention of Cardiovascular Events After Myocardial Infarction?
    Angiology, 2021, Volume: 72, Issue:6

    Topics: Acute Coronary Syndrome; Colchicine; Humans; Myocardial Infarction; Percutaneous Coronary Intervention

2021
Efficacy and safety of colchicine in the treatment of acute myocardial infarction: A protocol for systematic review and meta-analysis.
    Medicine, 2021, Apr-09, Volume: 100, Issue:14

    Topics: Anti-Inflammatory Agents; Clinical Protocols; Colchicine; Humans; Meta-Analysis as Topic; Models, Statistical; Myocardial Infarction; Systematic Review as Topic; Treatment Outcome

2021
Orbitrap-MS-based untargeted metabolomics study on the therapeutic effect of colchicine on myocardial infarction.
    Biomedical chromatography : BMC, 2021, Volume: 35, Issue:9

    Topics: Animals; Colchicine; Disease Models, Animal; Heart; Male; Metabolome; Metabolomics; Myocardial Infarction; Myocardium; Rats

2021
Effect of Colchicine on Myocardial Injury in Acute Myocardial Infarction.
    Circulation, 2021, 09-14, Volume: 144, Issue:11

    Topics: Acute Disease; Adult; Aged; Colchicine; Contrast Media; Female; Heart; Hospitalization; Humans; Male; Middle Aged; Myocardial Infarction; Myocardium; Referral and Consultation; ST Elevation Myocardial Infarction; Ventricular Remodeling

2021
Colchicine-Containing Nanoparticles Attenuates Acute Myocardial Infarction Injury by Inhibiting Inflammation.
    Cardiovascular drugs and therapy, 2022, Volume: 36, Issue:6

    Topics: Animals; Anti-Inflammatory Agents; Calcium Carbonate; Colchicine; Cytokines; Disease Models, Animal; Inflammation; Myocardial Infarction; Nanoparticles; Rats

2022
Low-Dose Colchicine for the Management of Coronary Artery Disease.
    Journal of the American College of Cardiology, 2021, 08-31, Volume: 78, Issue:9

    Topics: Atherosclerosis; Colchicine; Coronary Artery Disease; Humans; Myocardial Infarction

2021
Interest of colchicine in the treatment of acute myocardial infarct responsible for heart failure in a mouse model.
    International journal of cardiology, 2017, Aug-01, Volume: 240

    Topics: Animals; Colchicine; Disease Models, Animal; Heart Failure; Male; Mice; Mice, Inbred C57BL; Myocardial Infarction; Treatment Outcome; Tubulin Modulators

2017
Colchicine Improves Survival, Left Ventricular Remodeling, and Chronic Cardiac Function After Acute Myocardial Infarction.
    Circulation journal : official journal of the Japanese Circulation Society, 2017, Jul-25, Volume: 81, Issue:8

    Topics: Animals; Colchicine; Disease Models, Animal; Male; Mice; Myocardial Infarction; Recovery of Function; Ventricular Remodeling

2017
Cardioprotective Role of Colchicine Against Inflammatory Injury in a Rat Model of Acute Myocardial Infarction.
    Journal of cardiovascular pharmacology and therapeutics, 2018, Volume: 23, Issue:5

    Topics: Animals; Anti-Inflammatory Agents; Caspase 1; Colchicine; Disease Models, Animal; Drug Therapy, Combination; Inflammasomes; Interleukin-10; Interleukin-18; Interleukin-1beta; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Myocytes, Cardiac; NLR Family, Pyrin Domain-Containing 3 Protein; Rats, Wistar; Time Factors; Transforming Growth Factor beta1

2018
Colchicine In Epistenocardiac Pericarditis.
    Connecticut medicine, 2016, Volume: 80, Issue:9

    Topics: Aged; Colchicine; Drug Therapy, Combination; Female; Humans; Male; Myocardial Infarction; Pericarditis; Platelet Aggregation Inhibitors

2016
The Low Dose Colchicine after Myocardial Infarction (LoDoCo-MI) study: A pilot randomized placebo controlled trial of colchicine following acute myocardial infarction.
    American heart journal, 2019, Volume: 215

    Topics: Biomarkers; C-Reactive Protein; Colchicine; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Humans; Inflammation; Male; Middle Aged; Myocardial Infarction; Pilot Projects; Retrospective Studies; Time Factors; Treatment Outcome

2019
Update in rheumatology: evidence published in 2012.
    Annals of internal medicine, 2013, Jun-18, Volume: 158, Issue:12

    Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antirheumatic Agents; Antiviral Agents; Arthritis; Arthritis, Gouty; Arthritis, Rheumatoid; Autoimmune Diseases; Bacterial Infections; Calcitonin; Colchicine; Cryoglobulinemia; Death, Sudden, Cardiac; Drug Resistance, Viral; Enzyme Inhibitors; Female; Gout; Gout Suppressants; Hand Joints; Hepatitis C, Chronic; Humans; Hyperuricemia; Immunologic Factors; Janus Kinase 3; Male; Myocardial Infarction; Neoplasms; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Practice Guidelines as Topic; Protein Precursors; Pyrimidines; Pyrroles; Registries; Tumor Necrosis Factor-alpha

2013
Impact of allopurinol on risk of myocardial infarction.
    Annals of the rheumatic diseases, 2015, Volume: 74, Issue:5

    Topics: Aged; Allopurinol; Case-Control Studies; Colchicine; Female; Gout; Gout Suppressants; Humans; Hypertension; Logistic Models; Male; Middle Aged; Myocardial Infarction; Protective Factors

2015
Microtubule stabilization with paclitaxel does not protect against infarction in isolated rat hearts.
    Experimental physiology, 2015, Volume: 100, Issue:1

    Topics: Animals; Calcium Signaling; Colchicine; Cytoprotection; Dose-Response Relationship, Drug; Heart Rate; In Vitro Techniques; Male; Mechanotransduction, Cellular; Microtubules; Myocardial Infarction; Myocardial Reperfusion Injury; Myocytes, Cardiac; Paclitaxel; Rats, Sprague-Dawley; Stress, Mechanical; Tubulin Modulators; Ventricular Function, Left; Ventricular Pressure

2015
Differential Effects of Colchicine on Cardiac Cell Viability in an in vitro Model Simulating Myocardial Infarction.
    Cardiology, 2016, Volume: 134, Issue:1

    Topics: Animals; Apoptosis; Cell Line; Cell Survival; Colchicine; Mice; Myoblasts, Cardiac; Myocardial Infarction; Myocytes, Cardiac; Rats; Tubulin Modulators; Tumor Necrosis Factor-alpha

2016
Colchicine and Prevention of Cardiovascular Events.
    JAMA, 2016, Sep-13, Volume: 316, Issue:10

    Topics: Colchicine; Humans; Myocardial Infarction

2016
Colchicine use is associated with decreased prevalence of myocardial infarction in patients with gout.
    The Journal of rheumatology, 2012, Volume: 39, Issue:7

    Topics: Aged; Aged, 80 and over; Allopurinol; C-Reactive Protein; Colchicine; Female; Gout; Gout Suppressants; Humans; Male; Middle Aged; Myocardial Infarction; New York; Prevalence; Retrospective Studies; Treatment Outcome; Uric Acid

2012
Extremely high ferritin level after an acute myocardial infarction in an end stage renal disease patient.
    Clinical nephrology, 2014, Volume: 82, Issue:1

    Topics: Anemia, Hemolytic, Autoimmune; Asymptomatic Diseases; Biomarkers; Colchicine; Female; Ferritins; Humans; Hypotension; Kidney Failure, Chronic; Middle Aged; Myocardial Infarction; Pericardial Effusion; Pericardiocentesis; Renal Dialysis; Time Factors; Treatment Outcome; Up-Regulation

2014
ACUTE ANAPHYLACTOID REACTION TO PROBENECID.
    JAMA, 1965, Aug-30, Volume: 193

    Topics: Anaphylaxis; Colchicine; Diagnosis, Differential; Drug Therapy; Gout; Myocardial Infarction; Probenecid; Sulfinpyrazone; Toxicology

1965
Role of microtubules in ischemic preconditioning against myocardial infarction.
    Cardiovascular research, 2004, Nov-01, Volume: 64, Issue:2

    Topics: Animals; Biological Transport; Colchicine; Enzyme Activation; Enzyme Inhibitors; Ischemic Preconditioning, Myocardial; Male; Microtubules; Myocardial Infarction; Myocardium; Nocodazole; p38 Mitogen-Activated Protein Kinases; Perfusion; Protein Kinase C; Rabbits

2004
Evidence-based emergency medicine at the 'coal face'.
    Emergency medicine Australasia : EMA, 2005, Volume: 17, Issue:4

    Topics: Acyclovir; Adult; Chest Pain; Colchicine; Diagnosis, Differential; Emergency Medicine; Evidence-Based Medicine; Female; Ginkgo biloba; Gout Suppressants; Herpes Zoster; Humans; Male; Migraine Disorders; Myocardial Infarction; Pericarditis; Phytotherapy; Plant Preparations; Troponin

2005
Colchicine inhibits isoflurane-induced preconditioning.
    Anesthesiology, 1999, Volume: 91, Issue:6

    Topics: Anesthetics, Inhalation; Animals; Colchicine; Hemodynamics; Ischemic Preconditioning, Myocardial; Isoflurane; Myocardial Infarction; Rabbits; Ventricular Fibrillation

1999
Possible mechanism of cardioprotective effect of ischaemic preconditioning in isolated rat heart.
    Pharmacological research, 2000, Volume: 41, Issue:6

    Topics: Animals; Colchicine; Creatine Kinase; Female; In Vitro Techniques; Ischemic Preconditioning, Myocardial; L-Lactate Dehydrogenase; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Prazosin; Rats; Rats, Wistar

2000
Proposal for clinical trials using anti-inflammatory drugs in the therapy of angina pectoris, myocardial infarction and coronary restenosis after angioplasty and bypass grafting.
    Medical hypotheses, 1992, Volume: 37, Issue:2

    Topics: Angina Pectoris; Anti-Inflammatory Agents, Non-Steroidal; Arteriosclerosis; Clinical Trials as Topic; Colchicine; Griseofulvin; Humans; Myocardial Infarction; Recurrence; Sulfasalazine

1992
[Colchicine treatment of recurrent steroid-dependent pericarditis in a patient with post-myocardial-infarction syndrome (Dressler's syndrome)].
    Ugeskrift for laeger, 1992, Nov-23, Volume: 154, Issue:48

    Topics: Colchicine; Female; Humans; Middle Aged; Myocardial Infarction; Pericarditis; Prednisolone; Recurrence; Syndrome

1992
Possible cardioprotective effects of allopurinol.
    American journal of preventive medicine, 1988, Volume: 4, Issue:2 Suppl

    Topics: Acute Disease; Aged; Allopurinol; Cohort Studies; Colchicine; Drug Combinations; Female; Gout; Health Maintenance Organizations; Hospital Information Systems; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Reperfusion Injury; Probenecid; Time Factors; Washington

1988